Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
Der Urologe. Ausg. A
|
May 13, 2015
[Metastasized prostate cancer. Position paper on the use of chemotherapy]
C-H Ohlmann, S Duensing, R Eichenauer, et al.
Oncogene
|
July 5, 2006
RNA polymerase II transcription is required for human papillomavirus type 16 E7- and hydroxyurea-induced centriole overduplication
A Duensing, Y Liu, N Spardy, et al.
Cancer Biotherapy
|
January 1, 1993
Limited efficacy of interferon-alpha and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinoma
E Lopez Hanninen, M Fenner, H Kirchner, et al.
Der Urologe. Ausg. A
|
August 15, 2013
[Urology in the concept of comprehensive cancer centers]
B Hadaschik, S Pahernik, C Grüllich, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 16, 2000
The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle
S Duensing, L Y Lee, A Duensing, et al.
Nature
|
February 29, 1996
Rapid adaptive camouflage in tropical flounders
V S Ramachandran, C W Tyler, R L Gregory, et al.
Molecular Biotherapy
|
December 1, 1992
Pretreatment natural killer antigen density correlates to clinical response in tumor patients receiving long-term subcutaneous recombinant interleukin-2 and recombinant interferon-alpha
S Duensing, M Hadam, A Körfer, et al.
Oncology
|
March 1, 1996
Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma
G Anastassiou, S Duensing, G Steinhoff, et al.
World Journal of Urology
|
January 1, 1995
Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid
J Atzpodien, H Kirchner, S Duensing, et al.
The Clinical Investigator
|
July 1, 1994
Cytokine-based biotherapy of gastrointestinal tumors
J Buer, H Kirchner, A Schomburg, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
Der Urologe. Ausg. A
|
May 13, 2015
[Metastasized prostate cancer. Position paper on the use of chemotherapy]
C-H Ohlmann, S Duensing, R Eichenauer, et al.
Oncogene
|
July 5, 2006
RNA polymerase II transcription is required for human papillomavirus type 16 E7- and hydroxyurea-induced centriole overduplication
A Duensing, Y Liu, N Spardy, et al.
Cancer Biotherapy
|
January 1, 1993
Limited efficacy of interferon-alpha and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinoma
E Lopez Hanninen, M Fenner, H Kirchner, et al.
Der Urologe. Ausg. A
|
August 15, 2013
[Urology in the concept of comprehensive cancer centers]
B Hadaschik, S Pahernik, C Grüllich, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 16, 2000
The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle
S Duensing, L Y Lee, A Duensing, et al.
Nature
|
February 29, 1996
Rapid adaptive camouflage in tropical flounders
V S Ramachandran, C W Tyler, R L Gregory, et al.
Molecular Biotherapy
|
December 1, 1992
Pretreatment natural killer antigen density correlates to clinical response in tumor patients receiving long-term subcutaneous recombinant interleukin-2 and recombinant interferon-alpha
S Duensing, M Hadam, A Körfer, et al.
Oncology
|
March 1, 1996
Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma
G Anastassiou, S Duensing, G Steinhoff, et al.
World Journal of Urology
|
January 1, 1995
Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid
J Atzpodien, H Kirchner, S Duensing, et al.
The Clinical Investigator
|
July 1, 1994
Cytokine-based biotherapy of gastrointestinal tumors
J Buer, H Kirchner, A Schomburg, et al.
Page
of 8